SAMSUNG PHARM. Co., Ltd. (001360.KS) KSC

Currency In KRW

AD

Valuation

Market Cap144.07B
Enterprise Value150.6B
P/E Ratio-0.99
PEG Ratio-0.49
Price/Sales Ratio3.16
Price/Book Ratio1.87
Enterprise/Revenue3.48
Enterprise/EBITDA-9.32

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-3.21
Operating Margin-0.39
AD

Management Effectiveness

Return On Assets-1.13
Return On Equity-1.09

Income Statement

Revenue46.07B
Revenue/Share454.05
Gross Profit14.64B
EBITDA-18.06B
Net Income11.55B
Diluted EPS122.66

Balance Sheet

Total Cash9.56B
Total Cash/Share101.53
Total Debt18.6B
Total Debt/Equity0.26
Current Ratio0.77
Book Value Per Share767.75

Price History

52-Week Change-10.16
52-Week High2,320
52-Week Low1,140
Moving Average 50 Days1,309.46
Moving Average 200 Days1,587.5

Statistics

Average Volume349,395
Shares Outstanding94.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1093:1000
Last Split DateMay 02, 2018
AD